These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37944670)

  • 21. Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus.
    Mahmoud SA; Ganesan S; Ibrahim E; Thakre B; Teddy JG; Raheja P; Zaher WA
    J Med Virol; 2021 Sep; 93(9):5538-5543. PubMed ID: 34002401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens.
    De Pace V; Caligiuri P; Ricucci V; Nigro N; Galano B; Visconti V; Da Rin G; Bruzzone B
    BMC Infect Dis; 2021 Sep; 21(1):926. PubMed ID: 34493222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection.
    Bianco G; Boattini M; Barbui AM; Scozzari G; Riccardini F; Coggiola M; Lupia E; Cavallo R; Costa C
    J Clin Virol; 2021 Jun; 139():104838. PubMed ID: 33946040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis.
    Fragkou PC; Moschopoulos CD; Dimopoulou D; Ong DSY; Dimopoulou K; Nelson PP; Schweitzer VA; Janocha H; Karofylakis E; Papathanasiou KA; Tsiordras S; De Angelis G; Thölken C; Sanguinetti M; Chung HR; Skevaki C;
    Clin Microbiol Infect; 2023 Mar; 29(3):291-301. PubMed ID: 36336237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study.
    Corman VM; Haage VC; Bleicker T; Schmidt ML; Mühlemann B; Zuchowski M; Jo WK; Tscheak P; Möncke-Buchner E; Müller MA; Krumbholz A; Drexler JF; Drosten C
    Lancet Microbe; 2021 Jul; 2(7):e311-e319. PubMed ID: 33846704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Kashiwagi K; Miyazaki T; Tateda K
    J Infect Chemother; 2021 Feb; 27(2):319-322. PubMed ID: 33388232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2.
    Juscamayta-López E; Valdivia F; Horna H; Tarazona D; Linares L; Rojas N; Huaringa M
    Front Cell Infect Microbiol; 2021; 11():653616. PubMed ID: 34268131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochromatographic test for the detection of SARS-CoV-2 in saliva.
    Kashiwagi K; Ishii Y; Aoki K; Yagi S; Maeda T; Miyazaki T; Yoshizawa S; Aoyagi K; Tateda K
    J Infect Chemother; 2021 Feb; 27(2):384-386. PubMed ID: 33397587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study.
    Pickering S; Batra R; Merrick B; Snell LB; Nebbia G; Douthwaite S; Reid F; Patel A; Kia Ik MT; Patel B; Charalampous T; Alcolea-Medina A; Lista MJ; Cliff PR; Cunningham E; Mullen J; Doores KJ; Edgeworth JD; Malim MH; Neil SJD; Galão RP
    Lancet Microbe; 2021 Sep; 2(9):e461-e471. PubMed ID: 34226893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.
    Leuzinger K; Roloff T; Egli A; Hirsch HH
    Microbiol Spectr; 2022 Aug; 10(4):e0200622. PubMed ID: 35943268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept.
    Rusanen J; Kareinen L; Szirovicza L; Uğurlu H; Levanov L; Jääskeläinen A; Ahava M; Kurkela S; Saksela K; Hedman K; Vapalahti O; Hepojoki J
    mBio; 2021 May; 12(3):. PubMed ID: 34006662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of four commercial, automated antigen tests to detect SARS-CoV-2 variants of concern.
    Osterman A; Iglhaut M; Lehner A; Späth P; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Baiker A; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2021 Dec; 210(5-6):263-275. PubMed ID: 34415422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting.
    Seitz T; Lickefett B; Traugott M; Pawelka E; Karolyi M; Baumgartner S; Jansen-Skoupy S; Atamaniuk J; Fritsche-Polanz R; Asenbaum J; Wenisch C; Födinger M; Zoufaly A
    J Gen Intern Med; 2022 May; 37(6):1494-1500. PubMed ID: 35301660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-LAMP smartphone detection of SARS-CoV-2 on chip.
    Colbert AJ; Lee DH; Clayton KN; Wereley ST; Linnes JC; Kinzer-Ursem TL
    Anal Chim Acta; 2022 Apr; 1203():339702. PubMed ID: 35361434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay.
    Bordi L; Sberna G; Lalle E; Piselli P; Colavita F; Nicastri E; Antinori A; Boumis E; Petrosillo N; Marchioni L; Minnucci G; D'Agostini E; Castilletti C; Locatelli F; Zumla A; Ippolito G; Capobianchi MR; On Behalf Of Inmi ReCOVeRI Study Group
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33092065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycotic infection prevalence among patients undergoing bronchoalveolar lavage with search of SARS-CoV-2 after two negative nasopharyngeal swabs.
    Patrucco F; Airoldi C; Falaschi Z; Bellan M; Castello LM; Filippone F; Matranga S; Masellis S; Smeriglia A; Solidoro P; Balbo PE; Gavelli F
    J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34464944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community.
    Stohr JJJM; Zwart VF; Goderski G; Meijer A; Nagel-Imming CRS; Kluytmans-van den Bergh MFQ; Pas SD; van den Oetelaar F; Hellwich M; Gan KH; Rietveld A; Verweij JJ; Murk JL; van den Bijllaardt W; Kluytmans JAJW
    Clin Microbiol Infect; 2022 May; 28(5):695-700. PubMed ID: 34363945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of SARS-CoV-2 Detection by Rapid Antigen and by Three Commercial RT-qPCR Tests: A Study from Martin University Hospital in Slovakia.
    Dankova Z; Novakova E; Skerenova M; Holubekova V; Lucansky V; Dvorska D; Brany D; Kolkova Z; Strnadel J; Mersakova S; Janikova K; Samec M; Pokusa M; Petras M; Sarlinova M; Kasubova I; Loderer D; Sadlonova V; Kompanikova J; Kotlebova N; Kompanikova A; Hrnciarova M; Stanclova A; Antosova M; Dzian A; Nosal V; Kocan I; Murgas D; Krkoska D; Calkovska A; Halasova E
    Int J Environ Res Public Health; 2021 Jul; 18(13):. PubMed ID: 34280974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.